Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K RUdolf

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226H N Doods, W Wienen, M Entzeroth, et al.
European Journal of Pharmacology|September 21, 1993
Characterization of BIBN 99: a lipophilic and selective muscarinic M2 receptor antagonistH Doods, M Entzeroth, H Ziegler, et al.
Frontiers in Human Neuroscience|May 21, 2016
Neural Adaptations Associated with Interlimb Transfer in a Ballistic Wrist Flexion TaskKathy L Ruddy, Anne K Rudolf, Barbara Kalkman, et al.
Trends in Pharmacological Sciences|December 1, 1989
Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinicsW G Eberlein, W Engel, G Mihm, et al.
Human Brain Mapping|July 19, 2012
Neural adaptation to thin and fat bodies in the fusiform body area and middle occipital gyrus: an fMRI adaptation studyDennis Hummel, Anne K Rudolf, Marie-Luise Brandi, et al.
European Journal of Pharmacology|December 28, 1999
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonistH Doods, W Gaida, H A Wieland, et al.
Regulatory Peptides|August 27, 1996
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological propertiesH N Doods, H A Wieland, W Engel, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226H A Wieland, K D Willim, M Entzeroth, et al.
European Journal of Pharmacology|June 18, 1997
Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulationH Racchi, A J Schliem, M V Donoso, et al.
European Journal of Pharmacology|May 24, 1995
Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226M Entzeroth, H Braunger, W Eberlein, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226H N Doods, W Wienen, M Entzeroth, et al.
European Journal of Pharmacology|September 21, 1993
Characterization of BIBN 99: a lipophilic and selective muscarinic M2 receptor antagonistH Doods, M Entzeroth, H Ziegler, et al.
Frontiers in Human Neuroscience|May 21, 2016
Neural Adaptations Associated with Interlimb Transfer in a Ballistic Wrist Flexion TaskKathy L Ruddy, Anne K Rudolf, Barbara Kalkman, et al.
Trends in Pharmacological Sciences|December 1, 1989
Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinicsW G Eberlein, W Engel, G Mihm, et al.
Human Brain Mapping|July 19, 2012
Neural adaptation to thin and fat bodies in the fusiform body area and middle occipital gyrus: an fMRI adaptation studyDennis Hummel, Anne K Rudolf, Marie-Luise Brandi, et al.
European Journal of Pharmacology|December 28, 1999
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonistH Doods, W Gaida, H A Wieland, et al.
Regulatory Peptides|August 27, 1996
BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological propertiesH N Doods, H A Wieland, W Engel, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226H A Wieland, K D Willim, M Entzeroth, et al.
European Journal of Pharmacology|June 18, 1997
Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulationH Racchi, A J Schliem, M V Donoso, et al.
European Journal of Pharmacology|May 24, 1995
Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226M Entzeroth, H Braunger, W Eberlein, et al.
Pageof 9